| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/02/2011 | CN101291671B Liquid preparation for external application containing indomethacin |
| 02/02/2011 | CN101288772B Novel medical hot melt resin carrier gel matrix and its preparation method and application |
| 02/02/2011 | CN101273970B Microemulsion type preparation of glucocorticoid medicine for nasal cavity |
| 02/02/2011 | CN101269118B Chinese medicine extract catablasm for treating liver ascites and preparation method thereof |
| 02/02/2011 | CN101212987B Self-sterilizing products |
| 02/02/2011 | CN101203246B Medical composition |
| 02/02/2011 | CN101053670B Silk fibroin and polymeric lactic acid compound film and its preparation method |
| 02/01/2011 | USRE42096 FDA Orange book listed patent for amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate; sustained release for improved patient compliance, fewer dosages needed; attention deficit |
| 02/01/2011 | US7879994 Cellulose interpolymers and method of oxidation |
| 02/01/2011 | US7879993 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 02/01/2011 | US7879966 pH-sensitive polymer |
| 02/01/2011 | US7879899 Injectable veterinary composition for small animals |
| 02/01/2011 | US7879832 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 02/01/2011 | US7879831 Enhanced drug delivery in transdermal systems |
| 02/01/2011 | US7879817 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical |
| 02/01/2011 | US7879814 Administering adenosine 5'-monophosphate; side effect reduction |
| 02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879588 Protein-proteophore complexes |
| 02/01/2011 | US7879570 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer |
| 02/01/2011 | US7879560 Nanotube structures having a surfactant bilayer inner wall coating |
| 02/01/2011 | US7879373 comprises curcuminoid and an essential oil of turmeric; curcuminoid mixture consists of curcumin, demethoxycurcumin and bisdemethoxycurcumin and essential oil of turmeric comprises about 45% ar-turmerone |
| 02/01/2011 | US7879362 Oral pharmaceutical compositions with controlled release and prolonged absorption |
| 02/01/2011 | US7879359 Compositions for preparing external carbon dioxide agents |
| 02/01/2011 | US7879357 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
| 02/01/2011 | US7879356 AB block polymers, comprising a polylactone part made from monomers such as lactic acid, and B is derived from hydroxyl, amine, or carboxyl terminated compound endcapped with nonreactive group; storage stablity; anti-adhesions |
| 02/01/2011 | US7879346 Cosmetic compositions for improving the performance of transfer-resistant and long-wearing |
| 02/01/2011 | US7879343 Burn treatment method and composition |
| 02/01/2011 | US7879342 Vaccine adjuvant and making and using the same |
| 02/01/2011 | US7879335 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 02/01/2011 | US7879333 Methods for preparing and delivering adjuvant compositions |
| 02/01/2011 | US7879320 Sustained release interferon dosage form for use in treatment of multiple sclerosis |
| 02/01/2011 | US7879319 Selectively delivering interleukin-12 (IL-12) to a target antigen in a mammal |
| 02/01/2011 | US7879315 such as inositol phosphoric acid esters (phytic acid), polyphenols (Perilla frutescen var. crispa polyphenols), perilla extract comprising rosmarinic acid, phosphoric acids, edetic acid salts, tartaric acid, malic acid, citric acid, and glycolic acid |
| 02/01/2011 | CA2695611C Active targeting polymer micelle encapsulating drug, and pharmaceutical composition |
| 02/01/2011 | CA2570420C External preparation |
| 02/01/2011 | CA2543324C Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents |
| 02/01/2011 | CA2505918C A liposome having bound albumin and peg |
| 02/01/2011 | CA2488220C Medicament with delayed active constituent release containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol |
| 02/01/2011 | CA2483110C Use of a mare milk concentrate dried on a biologically inert, highly disperse matrix |
| 02/01/2011 | CA2481468C Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 02/01/2011 | CA2477881C Formoterol superfine formulation |
| 02/01/2011 | CA2466657C Soluble drug extended release system |
| 02/01/2011 | CA2464689C Modified release tamsulosin tablets |
| 02/01/2011 | CA2454804C Probiotic lactobacillus salivarius strains |
| 02/01/2011 | CA2445260C Buffer solution for electroporation and a method comprising the use of the same |
| 02/01/2011 | CA2427375C Pharmaceutical dronedarone composition for parenteral administration |
| 02/01/2011 | CA2412495C Conditioning of extracorporeal devices for extraction of toxic materials from mammalian body fluids using biotin derivatives |
| 02/01/2011 | CA2408685C Liquid pharmaceutical composition containing an erythropoietin derivate |
| 02/01/2011 | CA2405508C Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 02/01/2011 | CA2404368C Pharmaceutical compositions |
| 02/01/2011 | CA2402589C Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa |
| 02/01/2011 | CA2393298C Compositions and methods for stabilizing biological molecules upon lyophilization |
| 02/01/2011 | CA2353959C A medicinal aerosol formulation |
| 02/01/2011 | CA2345882C Methods and compositions for the prevention and treatment of anemia |
| 02/01/2011 | CA2342133C Ophthalmic formulations |
| 01/27/2011 | WO2011011675A1 Pharmaceutically acceptable formulations/compositions for peptidyl drugs |
| 01/27/2011 | WO2011011658A1 Adhesive complex coacervates and methods of making and using thereof |
| 01/27/2011 | WO2011011543A1 Oligomer-opioid agonist conjugates |
| 01/27/2011 | WO2011011517A2 Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof |
| 01/27/2011 | WO2011011351A2 A stable pharmaceutical omeprazole formulation for oral administration |
| 01/27/2011 | WO2011011347A2 Functionalization of silk material by avidin-biotin interaction |
| 01/27/2011 | WO2011010691A1 Polyion complex comprising phd2 expression inhibiting substance |
| 01/27/2011 | WO2011010645A1 Fentanyl-containing adhesive preparation for external use |
| 01/27/2011 | WO2011010605A1 Microneedle array |
| 01/27/2011 | WO2011010556A1 Transdermal preparation |
| 01/27/2011 | WO2011010456A1 EXTERNAL PREPARATION CONTAINING NSAIDs AND METHOD FOR PRODUCING THE EXTERNAL PREPARATION |
| 01/27/2011 | WO2011010399A1 Corneal endothelial cell proliferation promoter |
| 01/27/2011 | WO2011010324A1 Oral pharmaceutical composition of rasagiline and process for preparing thereof |
| 01/27/2011 | WO2011010156A1 Fas (apo-1, cd95) targeted platforms for intracellular drug delivery |
| 01/27/2011 | WO2011010084A2 Cyclosporin conjugates |
| 01/27/2011 | WO2011009956A1 Injectable aqueous solution containing artesunate |
| 01/27/2011 | WO2011009624A1 Delivery system and conjugates for compound delivery via naturally occurring intracellular transport routes |
| 01/27/2011 | WO2011009539A1 ε-POLYLYSINE CONJUGATES AND USE THEREOF |
| 01/27/2011 | WO2010140163A3 Non-implantable medical device coated with encapsulated nanoparticles containing therapeutic agents |
| 01/27/2011 | WO2010135534A3 Compositions for the treatment of metastatic cancer and methods of use thereof |
| 01/27/2011 | WO2010128087A3 Uses of immunoconjugates targeting cd138 |
| 01/27/2011 | WO2010119455A3 An injectable sustained release pharmaceutical composition |
| 01/27/2011 | WO2010065456A3 Flowable pharmaceutical depot |
| 01/27/2011 | WO2010041722A3 Pharmaceutical composition comprising a prostaglandin |
| 01/27/2011 | WO2010009065A3 Amphipathic peptide compositions |
| 01/27/2011 | WO2009156180A3 Polymeric delivery systems for active agents |
| 01/27/2011 | WO2009135855A3 Encapsulation of biologically active agents |
| 01/27/2011 | US20110021972 Composition and Device Structure For Iontophoresis |
| 01/27/2011 | US20110021899 Conductive polymer coatings |
| 01/27/2011 | US20110021761 Segmented Polymers and Their Conjugates |
| 01/27/2011 | US20110021643 Processed starch powder with excellent disintegration properties and manufacturing method thereof |
| 01/27/2011 | US20110021452 Lyophilized preparation of stabilized anthracycline compounds |
| 01/27/2011 | US20110021441 Conjugate comprising p21 protein for the treatment of cancer |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020458 Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| 01/27/2011 | US20110020457 Polymer-surfactant nanoparticles for sustained release of compounds |
| 01/27/2011 | US20110020450 Titratable dosage transdermal delivery system |
| 01/27/2011 | US20110020444 Abuse-resistant opioid dosage form |
| 01/27/2011 | US20110020422 Hydroxyapatite-Targeting Poly(ethylene glycol) and Related Polymers |
| 01/27/2011 | US20110020410 Stable solid preparations |
| 01/27/2011 | US20110020306 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020305 Probiotic, Lactic Acid-Producing Bacteria and Uses Thereof |
| 01/27/2011 | US20110020266 G-CSF Conjugates |
| 01/27/2011 | US20110020264 Method and Composition for the Treatment of Scars |